MarketBeat on MSN
Vir Biotechnology Q2 earnings call highlights
From laggards to leaders: Small caps on the rise Vir Biotechnology (NASDAQ:VIR) reported second-quarter 2026 results ...
Scientists at the Department of Energy's Oak Ridge National Laboratory have created a platform that pinpoints genetic triggers that turn microbes into efficient factories for new chemicals and ...
Upstream Biotechnology unlocks crops’ own defense systems in response to disease and environmental stress without ...
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...
SAN DIEGO, CA, UNITED STATES, August 4, 2026 /EINPresswire.com/ -- Key Takeaways ï‚·Investigational New Drug (IND) ...
SC451 for type 1 diabetes drives upside, but valuation & dilution risk loom. Click here to read more about the SANA stock.
More than 100 speakers will gather in the Saudi capital from 14 to 16 September for the fourth edition of the Summit, with delegations from over 70 countries expected to attend as the Kingdom builds ...
Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...
Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results